Pasar al contenido principal

CONDICIONAMIENTO Y MEMORIA DE LAS CELULAS PROGENITORAS DE OLIGODENDROCITOS (OPC): RECUERDAN LOS OPC LOS PROCESOS INFLAMATORIOS?

PID2021-124465OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNITAT VALENCIANA PARA LA GESTIÓN DEL INSTITUTO DE INVESTIGACIÓN SANITARIA Y BIOM

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Glial cell alterations in diabetes-induced neurodegeneration

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Immune–stem cell crosstalk in the central nervous system: how oligodendrocyte progenitor cells interact with immune cells

  • Cabeza-Fernández, Sonia
  • White, Jessica A.
  • McMurran, Christopher E.
  • Gómez-Sánchez, José A.
  • Fuente, Alerie G. de la
The interaction between immune and stem cells has proven essential for homeostasis and regeneration in a wide range of tissues. However, because the central nervous system was long considered an immune-privileged organ, its immune–stem cell axis was not deeply investigated until recently. Research has shown that oligodendrocyte progenitor cells (OPCs), a highly abundant population of adult brain stem cells, establish bidirectional interactions with the immune system. Here, we provide an overview of the interactions that OPCs have with tissue-resident and recruited immune cells, paying particular attention to the role they play in myelin regeneration and neuroinflammation. We highlight the described role of OPCs as key active players in neuroinflammation, overriding the previous concept that OPCs are mere recipients of immune signals. Understanding the mechanisms behind this bidirectional interaction holds great potential for the development of novel therapeutic approaches limiting neuroinflammation and promoting myelin repair. A better understanding of the central nervous system's immune–stem cell axis will also be key for tackling two important features shared across neurodegenerative diseases, neuroinflammation and myelin loss., This work was supported by the Miguel Servet Fellowship (CP21/00032) from the Instituto Carlos III to Alerie G de la Fuente, Plan Nacional 2021 from the Agencia Estatal de Investigación to Alerie G de la Fuente (PID2021-124465OA-I00), a grant from the Conselleria de Educació Generalitat Valenciana (PROMOTEO CIPROM/2021/048), which funds José A Gómez-Sánchez's postdoctoral position, a grant from the Northern Ireland Department of Economy and a grant from the Wellcome which funds Jessica A White's position., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Brain-specific regulatory T cell expansion limits cognitive decline

  • Llorián-Salvador, Maria
  • Fuente, Alerie G. de la
Recent work from Lemaitre and colleagues leveraged a central nervous system (CNS)-specific gene delivery approach to expand regulatory T cells (Treg) in aged mice. CNS-restricted Treg expansion reversed age-related glial cell transcriptomic changes and prevented aspects of cognitive decline, unveiling immune modulation as a potential approach to protect cognitive function with age., This work was funded by the Maria Zambrano fellowship from Spanish Ministry of Science, Innovation and Universities, financed by European Union ‘NextGenerationEU’ (Universitat Autónoma de Barcelona) to M.L.S., the Miguel Servet Fellowship from the Spanish Health Institute Carlos III to A.G.F. (CP21/00032) and a grant from the Spanish State Research Agency (PID2021-124465OA-I00) to A.G.F., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ageing impairs the regenerative capacity of regulatory T cells in mouse central nervous system remyelination

  • Guzman de la Fuente, Alerie
  • Dittmer, Marie
  • White, Jessica A.
  • Cabeza-Fernández, Sonia
  • Rodríguez-Baena, Francisco Javier
  • McMurran, Christopher E.
  • Franklin, Robin J. M.
  • Tiwari, Vijay K.
  • Fitzgerald, Denise C.
Alerie Guzman de la Fuente, Denise C. Fitzgerald., et al., Myelin regeneration (remyelination) is essential to prevent neurodegeneration in demyelinating diseases such as Multiple Sclerosis, however, its efficiency declines with age. Regulatory T cells (Treg) recently emerged as critical players in tissue regeneration, including remyelination. However, the effect of ageing on Treg-mediated regenerative processes is poorly understood. Here, we show that expansion of aged Treg does not rescue age-associated remyelination impairment due to an intrinsically diminished capacity of aged Treg to promote oligodendrocyte differentiation and myelination in male and female mice. This decline in regenerative Treg functions can be rescued by a young environment. We identified Melanoma Cell Adhesion Molecule 1 (MCAM1) and Integrin alpha 2 (ITGA2) as candidates of Treg-mediated oligodendrocyte differentiation that decrease with age. Our findings demonstrate that ageing limits the neuroregenerative capacity of Treg, likely limiting their remyelinating therapeutic potential in aged patients, and describe two mechanisms implicated in Treg-driven remyelination that may be targetable to overcome this limitation., This work was supported by the Wellcome Trust (110138/Z/15/Z to D.C.F.), Biotechnology and Biological Sciences Research Council (BB/J01026X/1 and BB/N003721/1, to D.C.F.), ECTRIMS postdoctoral fellowship (to A.G.F.), Wellcome ISSF fellowship (to A.G.F.), Miguel Servet Fellowship from the Spanish Institute of Health Carlos III (CP21/00032 to A.G.F.), Spanish State Research Agency Plan Generación de Conocimiento 2021 grant (PID2021-124465OA-I00 to A.G.F.), The Leverhulme Trust (ECF-2014-390, to Y.D.), a postdoctoral fellowship contract from the Generalitat Valenciana APOSTD21 (to F.J.R.) and postgraduate studentship support from the Dept. for the Economy (Northern Ireland)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glial cell alterations in diabetes-induced neurodegeneration

  • Llorián-Salvador, Maria
  • Cabeza-Fernández, Sonia
  • Gómez-Sánchez, José A.
  • Fuente, Alerie G. de la
Type 2 diabetes mellitus is a global epidemic that due to its increasing prevalence worldwide will likely become the most common debilitating health condition. Even if diabetes is primarily a metabolic disorder, it is now well established that key aspects of the pathogenesis of diabetes are associated with nervous system alterations, including deleterious chronic inflammation of neural tissues, referred here as neuroinflammation, along with different detrimental glial cell responses to stress conditions and neurodegenerative features. Moreover, diabetes resembles accelerated aging, further increasing the risk of developing age-linked neurodegenerative disorders. As such, the most common and disabling diabetic comorbidities, namely diabetic retinopathy, peripheral neuropathy, and cognitive decline, are intimately associated with neurodegeneration. As described in aging and other neurological disorders, glial cell alterations such as microglial, astrocyte, and Müller cell increased reactivity and dysfunctionality, myelin loss and Schwann cell alterations have been broadly described in diabetes in both human and animal models, where they are key contributors to chronic noxious inflammation of neural tissues within the PNS and CNS. In this review, we aim to describe in-depth the common and unique aspects underlying glial cell changes observed across the three main diabetic complications, with the goal of uncovering shared glial cells alterations and common pathological mechanisms that will enable the discovery of potential targets to limit neuroinflammation and prevent neurodegeneration in all three diabetic complications. Diabetes and its complications are already a public health concern due to its rapidly increasing incidence, and thus its health and economic impact. Hence, understanding the key role that glial cells play in the pathogenesis underlying peripheral neuropathy, retinopathy, and cognitive decline in diabetes will provide us with novel therapeutic approaches to tackle diabetic-associated neurodegeneration., This work was supported by a Miguel Servet Fellowship from the Spanish Health Institute Carlos III (CP21/00032 to AGF), a grant from the Spanish State Research Agency corresponding to “Plan Nacional 2021” (PID2021-124465OA-I00 to AGF), the Maria Zambrano fellowship from Spanish Ministry of Science, Innovation and Universities, financed by European Union “NextGenerationEU” (Universitat Autònoma de Barcelona, to MLS), a Miguel Servet Fellowship from the Spanish Health Institute Carlos III (CP22/00078 to JAGS), a grant from the Spanish State Research Agency corresponding to “Plan Nacional 2022” (PID2022-143269OB-I00 to JAGS) and a grant from the “X Convocatoria Intramural 2023” from ISABIAL (Modality F to AGF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Navigating the transition to Principal Investigator

  • Fuente, Alerie G. de la
As the result of many years of training, becoming a Principal Investigator (PI) is an exciting but also stressful and intimidating career transition step. While navigating this transition we quickly find out that the skills we have crafted throughout our scientific training do not necessarily cover those required to successfully run a research group. Although there is not a common path to ensure success for all new PIs, many of us encounter similar hurdles. The aim of this article is to reflect on my recent experience and mistakes 2 years after initiating this transition, in the hope of highlighting some key aspects that may be beneficial for future new PIs., Dr Guzman de la Fuente's research is supported by the Miguel Servet Fellowship from the Instituto de Salud Carlos III (CP21/00032) and the project PID2021-124465OA-I00 funded by the Spanish State Research Agency (AEI) and the “Union Europea Next Generation EU”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Regulatory T cell expansion prevents retinal degeneration in type 2 diabetes

  • Llorián-Salvador, Maria
  • Pérez-Martínez, Daniel
  • Tang, Miao
  • Duarri, Anna
  • García-Ramírez, Marta
  • Deàs-Just, Anna
  • Álvarez-Guaita, Anna
  • Ramos-Pérez, Lorena
  • Bogdanov, Patricia
  • Gómez-Sánchez, José A.
  • Stitt, Alan W.
  • Hernández Pascual, Cristina
  • Fuente, Alerie G. de la
  • Simó, Rafael
[Background] The global incidence of type 2 diabetes (T2D) is rapidly increasing, with retinopathy being its most common complication and a leading cause of preventable blindness. Although the precise mechanisms involved in the development of diabetic retinopathy (DR) are not fully understood, defective immunomodulation is a recognized key factor in its pathophysiology. Regulatory T cells (Treg) regulate inflammation and promote regeneration, and while they are known to have important anti-inflammatory and neuroprotective roles in other tissues, including central nervous system, their role in the diabetic retina remains largely unknown. The aim of the present study is to examine the effect of Treg expansion of retinal neurodegeneration, an early event in the pathogenesis of DR., [Methods] Treg expansion was achieved by co-injecting recombinant mouse IL-2 with anti-IL-2 monoclonal antibody or its isotype in db/db mice as an established model of T2D. Treg expansion was confirmed via flow cytometry in blood, spleen, and retina. Fundus angiography was performed in the days prior to animal sacrifice at 18 weeks. To study the effect of Tregs on retinal neurons, glia and vascular permeability, immunohistochemistry against Cone-Arrestin, PKCα, synaptophysin, ChAT, TH, GFAP, Iba-1, calbindin, Brn3a, RBPMS, isolectin B4, and albumin was used. Retinal VEGF levels were measured with a magnetic bead-based immunoassay, and NLRP3, Casp1, p20 and IL-18 were analyzed by Western Blot in retinal homogenates., [Results] There was a significant decrease in Treg in db/db mice blood. When this deficiency was corrected in db/db mice by systemic Treg expansion, there was an effective protection against retinal neurodegenerative, gliotic, inflammatory changes and vascular leakage associated with T2D. Importantly, Treg expansion did not impact the T2D phenotype in db/db mice as evaluated by blood glucose, HbA1c and circulating insulin., [Conclusion] Treg modulation in T2D offers a promising therapeutic approach to prevent early stages of DR. This strategy focuses on reducing neuroinflammation and mitigating the associated neuronal, glial, and vascular degenerative changes characteristic of DR., This work has been partially supported by Col·legi Oficial de Farmacèutics de Barcelona. M.L.S.: Maria Zambrano fellowship from Spanish Ministry of Science, Innovation and Universities, financed by European Union “NextGenerationEU” (Universitat Autònoma de Barcelona), and Beatriu de Pinos fellowship, financed by Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, Generalitat de Catalunya). AGF research is supported by a Miguel Servet Fellowship from the Spanish Health Institute Carlos III (CP21/00032) and a grant from the Spanish State Research Agency corresponding to “Proyectos de Generación del Conocimiento 2021” (PID2021-124465OA-I00 funded by MICIU/AEI/13.13039/501100011033/ERDF, EU). JAGS research is supported by a Miguel Servet Fellowship from the Spanish Health Institute Carlos III (CP22/00078) and a grant from the Spanish State Research Agency corresponding to “Proyectos de Generación del Conocimiento 2022” (PID2022- 143269OB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Schwann cell JUN expression worsens motor performance in an amyotrophic lateral sclerosis mouse model

  • Cabeza-Fernández, Sonia
  • Hernández-Rojas, Rubí
  • Casillas-Bajo, Angeles
  • Patel, Nikiben
  • Fuente, Alerie G. de la
  • Cabedo, Hugo
  • Gómez-Sánchez, José A.
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease characterized by motor neuron death and distal axonopathy. Despite its clinical severity and profound impact in the patients and their families, many questions about its pathogenesis remain still unclear, including the role of Schwann cells and axon-glial signaling in disease progression. Upon axonal injury, upregulation of JUN transcription factor promotes Schwann cell reprogramming into a repair phenotype that favors axon regrowth and neuronal survival. To study the potential role of repair Schwann cells on motoneuron survival in amyotrophic lateral sclerosis, we generated a mouse line that over-expresses JUN in the Schwann cells of the SOD1G93A mutant, a mouse model of this disease. Then, we explored disease progression by evaluating survival, motor performance and histology of peripheral nerves and spinal cord of these mice. We found that Schwann cell JUN overexpression does not prevent axon degeneration neither motor neuron death in the SOD1G93A mice. Instead, it induces a partial demyelination of medium and large size axons, worsening motor performance and resulting in more aggressive disease phenotype., This work was supported by the Plan Nacional 2019 from the Agencia Estatal de Investigación to HC (PID2022-141062OB-I00), a grant from the Conselleria de Educació Generalitat Valenciana to HC (PROMETEO CIPROM/2021/048), the Plan Nacional 2021 from the Agencia Estatal de Investigación to AGDLF (PID2021-124465OA-I00), the Miguel Servet Fellowships from the Instituto Carlos III to AGDLF (CP21/00032) and to JAGS (CP22/00078) and a grant from the Convocatoria Intramural 2024 (ISABIAL) to JAGS The Instituto de Neurociencias is a ‘‘Center of Excellence 954 Severo Ochoa” (Ministerio de Economía y Competitividad SEV-2013-0317)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (SEV-2013-0317), Peer reviewed